Hair Relaxer Lawsuit

122 results
A federal judge has determined that a $25 million Philips CPAP medical monitoring settlement is “fair, reasonable and adequate”, providing funding to monitor individuals exposed to toxic foam released by recalled breathing machines.
The FDA has indicated that a change of instructions for the Philips OmniLab Advanced+ to prevent loss of therapy constitutes a class I recall notice, following reports of more than a dozen injuries and one patient death.
The FDA has determined that instructions issued by the manufacturer to fix problems linked to 65 patient deaths should be classified as a Class I recall, due to the risk of device failure which could result in loss of therapy.
Philips has agreed to pay $1.1 billion to resolve all Philips CPAP personal injury and medical monitoring lawsuits after receiving final approval on another deal to resolve class action economic loss claims as well.
A scheduling order issued by a federal judge calls for parties to have a plan to select potential Philips CPAP injury lawsuit bellwether selections by the end of October.
A federal judge has approved a consent decree restricting Philips CPAP sales and manufacturing due to the company's failures to meet U.S. manufacturing standards and to remediate recalled devices properly following a 2021 recall.
Notifications